相关产品推荐更多 >

Anti-PRUDU6 Antibody (SAA0750)
¥1338
Anti-Listeria monocytogenes serotype 1/2a InlB/Internalin B Nanobody (SAA0997)
¥1338
SRP14 Polyclonal Antibody(多克隆抗体) | SRP14 Antibody | SRP14抗体
¥3900
NCF2 Polyclonal Antibody(多克隆抗体), FITC conjugated | NCF2 Antibody, FITC conjugated | NCF2抗体, FITC conjugated
¥880
Anti-Monkey CD3E Antibody (SAA2708)
¥1338
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 亚型:
IgG
- 形态:
Liquid
- 保存条件:
-20°C
- 克隆性:
单克隆
- 适应物种:
Mycobacterium tuberculosis
- 保质期:
twelve months
- 级别:
一抗
- 供应商:
武汉研升生物科技有限公司
- 宿主:
Human
- 应用范围:
ELISA: 1:2000-1:20000; WB: 1:500-1:2000
- 抗体英文名:
Anti-Mycobacterium tuberculosis LAM Antibody (SAA2588)
- 规格:
50μg/100μg/1mg
| 规格: | 50μg | 产品价格: | ¥1338.0 |
|---|---|---|---|
| 规格: | 100μg | 产品价格: | ¥2288.0 |
| 规格: | 1mg | 产品价格: | ¥9188.0 |
| 产品名 | Anti-Mycobacterium tuberculosis LAM Antibody (SAA2588) |
| 货号 | YC145013 |
| 宿主 | Human |
| 种属反应性 | Mycobacterium tuberculosis |
| 克隆类型 | Monoclonal |
| 克隆号 | SAA2588 |
| Accession号 | ChEBI: 59524 |
| 靶标 | LAM, lipoarabinomannan |
| 同种型 | IgG |
| 应用 | ELISA, FCM, WB, IF |
| 应用范围 | ELISA: 1:2000-1:20000; WB: 1:500-1:2000 |
| 内毒素水平 | Please contact with the lab for this information. |
| 纯化方式 | Protein A/G purified from cell culture supernatant. |
| 纯度 | >95% as determined by SDS-PAGE. |
| 状态 | Liquid |
| 保存溶液 | 0.01M PBS pH 7.4 |
| 稳定性和存储 | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| 说明 | For research use only. |

风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验, or complementation of cell defects. Here we describe the detailed construction of a genomic, random shear lambda expression library, adsorption of anti Escherichia coli antibody from antiserum, the screening of an expression library with specific antisera
The Immunology of DNA Vaccines
: Mycobacterium tuberculosis, Mycoplasma pulmonis , and Borrelia burgdorferi ; as well as parasites, such as malaria and leishmania (4 ). Phase I clinical vaccine trials are currently being performed for HIV, HBV, and influenza virus. With the molecular
bioassay[J].GenomeRes.2001,11(11):1888—1898.[4]Fuhon RJ,McDade RL.Smith PL,et al.Advanced multiplexedanalysis with the Flow Metrixsystem[J].Clin Chem,1997,43(9)l749一l756.[5]Cowan LS.Diem L,Brake MC,et al.Transfer of a Mycobacterium tuberculosis genotyping
技术资料暂无技术资料 索取技术资料





